期刊文献+

IFN-γ抗结核分枝杆菌感染的实验观察 被引量:2

Experimental Observation of INF-γ on Resistance to Mycobacterium Turbercuiosis Infection
下载PDF
导出
摘要 目的 观察IFN -γ抗结核分枝杆菌感染的作用。方法 将BALB/c小鼠制成结核分枝杆菌感染模型 ,随机分为 4组 ,分别以IFN -γ、LVFX、IFN -γ +LVFX及PBS治疗 ,检测重要脏器菌落数 ,观察小鼠平均生存时间。结果 各治疗组肝、脾、肺组织菌落数均显著低于对照组 ,尤其IFN -γ +LVFX治疗组效果更为明显 ;治疗组小鼠平均生存期均显著高于对照组 (P <0 .0 1)。结论 外源性IFN -γ可减少肝、脾、肺组织中结核分枝杆菌菌落数 ,延长动物生存时间 ,促进Th1细胞的免疫应答 ,在抗结核分枝杆菌感染中起着重要作用。 Objective To study the effect of IFN-γ on resistance of BALB/c mice to Mycobacterium tuberculosis infection.Methods The BALB/c mice infected with Mycobacterium tuberculosis were randomly divided into four groups and were treated with IFN-γ,LVFX,IFN-γ+LVFX and PBS,respectively.The colonies of bacteria in major organ were counted and the survival times of the mice were observed.Results In three treated groups the bacterial colonies in liver,spleen and lung were markedly reduced than that in control group,especially in IFN-γ+LVFX combined treated group.In the treated groups the mean survival time of the mice was longer than that in the control group ( P <0.01).Conclusion This study shows that exogenous IFN-γ could decrease the bacterial colonies in liver,spleen and lung,extend the survival time of mice infected with Mycobacterium tuberculosis, and promote immune response of Thl cells.It suggests that IFN-γ could play an important role in anti-tuberculosis protection in mice.
出处 《苏州大学学报(医学版)》 CAS 2002年第5期526-527,539,共3页 Suzhou University Journal of Medical Science
关键词 实验观察 结核分枝杆菌 IFN-Γ 小鼠 免疫治疗 Mycobacterium tuberculosis IFN-γ immunotherapy
  • 相关文献

同被引文献30

  • 1简清梅.苦参碱抑制结核菌的药效分析[J].现代医药卫生,2005,21(21):2890-2891. 被引量:4
  • 2宋文刚,孔祥宇,韩中波,崔新颖,王丽.茜草素在体外抗菌活性的研究[J].中国地方病防治,2007,22(1):69-70. 被引量:9
  • 3Trouiller P,OUiaro P.Drug Development Output during 1975-96:What Proportion for Tropical Diseases[J].IntInfect Dis,1999,3:61-63.
  • 4全国利福喷丁科研协作组.国产利福喷丁治疗结核病的系列研究.结核病与胸部肿瘤,1999,33(11):1202-1210.
  • 5雷招宝.利福布丁治疗肺结核病人的疗效和安全性.国外医学:药学分册,(4):248-249.
  • 6Ji B,Lounis N,Maslo C,et al.In Vitro and in Vivo Activity of Moxifloxacin and Clinafloxacin against Mycobacterium Tuberculosis[J].Antimicrob Agents Chemoter,1998,42(8):2066-2069.
  • 7Miyazaki E,Miya,ski M,Chen J M,et al.Moxifloxac in (BAYl2-8039),a New 8-Methoxy-quinolone,Is Active in a Mouse Model of Tuberculosis[J].Anfimicrob Agents Chemother,1999,43(1):85-89.
  • 8Alvirez-Freites E J,Carter J L,Cynamon M H.In Vitro and in Vivo Activities of Moxifloxacin and Clinafloxacin againat Mycohecterium Tuberculosis[J].Antimicrob Agents Chemother,2002,46(4):1022-1025.
  • 9Raastosi N,Labroosse V,Bryskier A.Intracellular Activities ofRoxithromycin Used Alone and in Association with Other Drugs against Mycobacterium Avium Complexin Human Macrophages[J].Antimiemb Agents Chemother,1995,39(4):967-978.
  • 10Koletar S L,Berry A J,Cynamon M H,et al.Azithromycin as Treatment for Disseminated Mycobacterium Avium Complex in AIDS Patients[J].Anfimicrob Agents Chemother,1999,43(12):2869-2872.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部